We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-1.7%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$439B
AUM Growth
+$49B
Cap. Flow
+$65.7B
Cap. Flow %
14.98%
Top 10 Hldgs %
33.97%
Holding
14,356
New
1,622
Increased
5,458
Reduced
5,222
Closed
1,858

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$703M
2
TSLA icon
Tesla
TSLA
+$585M
3
JPM icon
JPMorgan Chase
JPM
+$582M
4
AMZN icon
Amazon
AMZN
+$566M
5
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$466M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$349M
2
HD icon
Home Depot
HD
+$334M
3
TMUS icon
T-Mobile US
TMUS
+$270M
4
CI icon
Cigna
CI
+$258M
5
CDW icon
CDW
CDW
+$237M

Sector Composition

Rank Sector Weight
1 Technology 3.12%
2 Healthcare 2.55%
3 Financials 2.39%
4 Consumer Discretionary 2.14%
5 Industrials 1.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMCR icon
10401
CALL
Amcor
AMCR
$21.3B
$185K ﹤0.01%
3,440
-540
-14% -$33.1K
HBM icon
10402
CALL
Hudbay
HBM
$11.9B
$185K ﹤0.01%
45,800
+18,300
+67% +$73.3K
PRVB
10403
PUT
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$185K ﹤0.01%
41,000
+4,100
+11% +$18.7K
POTX
10404
CALL
DELISTED
Global X Cannabis ETF
POTX
$185K ﹤0.01%
+13,512
New +$228K
DOC
10405
PUT
DELISTED
PHYSICIANS REALTY TRUST
DOC
$185K ﹤0.01%
12,300
-7,100
-37% -$120K
HIVE
10406
PUT
HIVE Digital Technologies
HIVE
$736M
$184K ﹤0.01%
48,900
-17,260
-26% -$78.2K
KEMQ icon
10407
KraneShares Public-Private Emerging Markets Internet and Technology ETF
KEMQ
$26.2M
$184K ﹤0.01%
+13,958
New +$214K
MAX icon
10408
MediaAlpha
MAX
$807M
$184K ﹤0.01%
20,997
-70,595
-77% -$687K
VLDR
10409
CALL
DELISTED
Velodyne Lidar, Inc. Common Stock
VLDR
$184K ﹤0.01%
193,800
+94,400
+95% +$110K
NVIV
10410
DELISTED
InVivo Therapeutics Holdings Corp
NVIV
$184K ﹤0.01%
42,794
+27,667
+183% +$151K
CWK icon
10411
PUT
Cushman & Wakefield Ltd
CWK
$3.38B
$183K ﹤0.01%
+16,000
New +$241K
DX
10412
Dynex Capital
DX
$3.24B
$183K ﹤0.01%
15,694
-214,779
-93% -$3.36M
HCAT icon
10413
PUT
Health Catalyst
HCAT
$139M
$183K ﹤0.01%
+18,900
New +$250K
TBPH icon
10414
CALL
Theravance Biopharma
TBPH
$881M
$183K ﹤0.01%
18,000
+8,000
+80% +$75K
ALTU
10415
DELISTED
Altitude Acquisition Corp
ALTU
$183K ﹤0.01%
18,254
-103,924
-85% -$1.04M
CHIU
10416
DELISTED
Global X MSCI China Utilities ETF
CHIU
$183K ﹤0.01%
13,342
+1
+0% +$16
FRBNW
10417
DELISTED
Forbion European Acquisition Corp. Warrants
FRBNW
$183K ﹤0.01%
763,769
+13,569
+2% +$2.09K
HCIC
10418
CALL
DELISTED
Hennessy Capital Investment Corp. V Class A Common Stock
HCIC
$183K ﹤0.01%
18,500
-5,400
-23% -$53.2K
BNBX
10419
DELISTED
BNB PLUS CORP
BNBX
$182K ﹤0.01%
11
+8
+267% +$273K
FBRT
10420
PUT
Franklin BSP Realty Trust
FBRT
$670M
$182K ﹤0.01%
+16,900
New +$232K
MVST icon
10421
PUT
Microvast
MVST
$322M
$182K ﹤0.01%
100,400
+45,800
+84% +$109K
NEXA icon
10422
PUT
Nexa Resources
NEXA
$1.88B
$182K ﹤0.01%
+35,200
New +$203K
SCPH
10423
DELISTED
scPharmaceuticals
SCPH
$182K ﹤0.01%
27,936
-19,298
-41% -$103K
WALD icon
10424
Waldencast
WALD
$173M
$182K ﹤0.01%
18,225
-1,803,473
-99% -$16M
BYRN icon
10425
Byrna Technologies
BYRN
$95.5M
$181K ﹤0.01%
38,531
-55,498
-59% -$437K

Similar funds

Ken Griffin's Q3 2022 Portfolio in Review

As of Q3 2022, Ken Griffin held 14,356 positions worth $439B, up 13% from $390B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Ken Griffin deployed $65.7B of net new capital in Q3 2022, opening 1,622 new positions and adding to 5,458 existing holdings. Its largest new stake was SentinelOne: 4,426,634 shares worth $113M.

By sector, the portfolio is most concentrated in Technology at 3.1% of assets, up from 2.8% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $349M trimmed.

  • Ken Griffin's largest Q3 2022 buy was SentinelOne: 4,426,634 shares worth $113M.
  • Ken Griffin added most to Apple in Q3 2022, an estimated $703M increase.
  • Ken Griffin's biggest Q3 2022 reduction was Meta Platforms (Facebook), cutting an estimated $349M.
  • Ken Griffin fully exited Regions Financial in Q3 2022, selling an estimated $207M.
  • Ken Griffin's ten largest holdings make up 34% of its $439B portfolio in Q3 2022.
  • Ken Griffin opened 1,622 new positions and closed 1,858 in Q3 2022.
  • Ken Griffin's portfolio value rose 13% quarter-over-quarter to $439B.

Based on Citadel Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.